[DOI] [PubMed] [Google Scholar] 69.Rijkelijkhuizen J.M., McQuarrie K., Girman C.J., Stein P.P., Mari A., Holst J.J., et al
[Abstract]2022 Mar:102:102527
Using split doses for the first 4 to 8 weeks while adapting to the glucagon component, then consolidating to weekly injections, is a pragmatic approach that some researchers report success with
All the technologies behind a GLP-1 platform (back-end systems, mobile and web applications, cloud infrastructure, and third-party services) must be tightly integrated to operate reliably
This research was supported by a research grant award from European Study for the Study of Diabetes (EFSD) as European Research Grant Award (EFSD/Sanofi programme, whose recipient was LLS) and by the Italian Ministry of Health Ricerca Corrente grant to IRCCS MultiMedica
Even RF micro needling treatments, that have recently become popular, can be uncomfortable, risky and require downtime